Labiotech Resources Archive - Page 2 of 2 - Labiotech.eu

Inpart RD report Biotech assets 1

Produced by

R&D trends: Biotech assets & discovery platforms

Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.

Produced by

Partnering 2030: FME Industries Report

Produced by

Produced by

Partnering 2030: Biopharma Report

Produced by

Produced by

Antibody Therapy R&D trends and breakthrough innovations

Produced by

Current trends & innovations in 3D organoids

Outsourcing in life science R&D today

New frontiers in vaccinology

Cell Therapy Industry Report 2022

The European Biotech Startup Ecosystem

Gene Therapy Industry Report 2021

European Biotech Industry Report 2021

The Genome Editing Toolbox: ZFNs, TALENs, and CRISPR in Biomedicine

Navigating the Immunotherapy Maze

Guidelines for Early-Stage Biotechs

Current and Emerging Approaches for Autoimmune Diseases

A Guide to Current Therapies in Immuno-Oncology

The Human Kinome: A Study of Protein Kinases

Peptides and Nucleic Acid Therapeutics: Dancing a Triumphant Tango

Antibodies Through the Magnifying Glass: Their Past, Present and Future

Beyond the Gut: An Atlas of the Human Microbiome

A Toolkit for Emerging Biotechs: Practical Advice For Clinical Development

The Digital Transformation of the Research Lab: From Pen & Paper to Voice Recognition & AI